STI/BBV testing tool for asymptomatic people

NSW STI Programs Unit, ASHM & Qld. Govt.,  2019

This resource has charts and information about how routine STI/BBV testing can be offered, who to, and how to follow up.

Developed by NSW STI Programs Unit, NSW Australia, and reproduced with permission by the Sunshine Coast Hospital and Health Service, ASHM and Communicable Diseases Branch.

 

 

A guide to My Health Record: for BBV & STI healthcare providers to support their patients

ASHM  (Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine)

Healthcare providers can play a crucial role in helping patients make informed decisions about whether and indeed the extent, to engage with the My Health Record, particularly for those patients with BBVs and/or other potentially stigmatising conditions.

To support those conversations, ASHM has created A guide to My Health Record: for BBV & STI healthcare providers to support their patients. The guide outlines the key issues associated with My Health Record, and provides four key recommendations to clinicians around advising patients on how to engage with the system.

Though the opt-out period ends soon, clinicians still have an ongoing obligation to provide advice to patients around the benefits as well as the privacy and security control options available, to guide their decision-making around engaging with My Health Record.

With increased media attention on My Health Record in recent weeks, some specifics of the system may change. A guide to My Health Record is a living document and will be updated with any relevant changes as further details emerge.

HIV PrEP update & HIV prescriber update in Adelaide

ASHM, October 2018

HIV PrEP Update for GPs and Practice Nurses

This training will provide GPs, Nurses, and Health Professionals working in primary care an update on strategies available for the prevention of HIV transmission, focusing on prevention particularly pre-exposure prophylaxis (PrEP).

– Date Tuesday, 23 October 2018
– Venue Mercure Grosvenor, 125 North Terrace, Adelaide SA 5000
– Time 6:15pm – 9:30 pm (Registration from 6:15pm, webinar broadcasts from 6:45pm)

At the end of this update, participants will be able to;
– Describe HIV epidemiology in Australia and the different HIV prevention
strategies
– Explain the role of HIV treatment and management
–  Provide patient education on the effectiveness and appropriate use of
PrEP/PEP
– Identify the prescribing pathways of PrEP within your local jurisdiction

This evening educational session will be presented by Dr Charlotte Bell, Sexual
Health Physician – Royal Adelaide Hospital.

This course is also available as a webinar, please contact Emma Williams here
for webinar registration

Register for this course at:
http://www.ashm.org.au/training/
Registrations close: Friday, 19 October 2018

Download flyer here: HIV PrEP Update_23Oct2018


HIV s100 Prescriber Dinner Update: 2018 IAS Conference Report Back and
Complex HIV Case Discussion

ASHM would like to invite HIV s100 Prescribers and medical practitioners in South Australia to attend this dinner training.

– Date Wednesday, 24 October 2018
– Venue Mercure Grosvenor, 125 North Terrace, Adelaide SA 5000
– Time 6:15pm – 9:30 pm (Registration starts 6:15pm, Webinar from 6:50pm)
– Cost FREE, Dinner and refreshments will be provided on site

This dinner workshop will bring attendees an overview of the content showcased at the
2018 International AIDS Conference held in Amsterdam, as well as a number of complex HIV cases to discuss. The first session is a conference report back
session. Professor Mark Boyd will provide an update on the latest studies, important
developments and best research methods in the ongoing battle against HIV, AIDS and
related infectious diseases from the IAS Conference 2018.

The second session will be an interactive panel discussion, focussing on the
management of complex HIV cases. Panellists include Professor Mark Boyd, Dr Russell Waddell (Consultant Sexual Health Physician and Clinical Director STD Services, Royal Adelaide Hospital) and Dr Andrew Beckwith (Senior Consultant Psychiatrist, Director of Training, HIV/Hep C Liaison Psychiatrist, CALHN Mental Health). The session will be hosted by Dr Samuel Elliott (Principal General Practitioner, Riverside Family Medical Practice).

This course is also available as a webinar, please contact Emma Williams here
for webinar registration

Register for this course at:
http://www.ashm.org.au/training/
Registrations close: Friday, 19 October 2018

Download flyer here: HIV Prescriber Update_24Oct2018

The time for action on Human T-Lymphotrophic Virus has arrived: An open letter to WHO

Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine (ASHM), 10 May 2018

ASHM has joined the call by leading Human T-Lymphotrophic Virus 1 (HTLV-1) researchers, clinicians and patients to take action on HTLV-1 by signing an open letter to the WHO, published in an abbreviated form in The Lancet. The letter calls on the WHO to support the promotion of proven, effective transmission prevention strategies for HTLV-1, in much the same way it already does for HIV, HBV and HCV.

ASHM established an 2016, to bring together researches, clinicians and community representatives at an annual round table to raise awareness of HTLV-1 and share the latest information. Up to 40% of the  HTLV-1 working group ipopulation of some Central Australian communities are positive for HTLV-1, which can cause cancer, neurological problems and immune disorders, including chronic lung inflammation leading to bronchiectasis.

“Specifically for Australia, we have all of the key components required for an effective response to this virus – indigenous clinical leadership; the medical research skills and capacity; and two forthcoming developments in treatment and vaccine development,” said Professor Damian Purcell, Head of Molecular Virology Laboratory, The University of Melbourne at the Doherty Institute and member of the ASHM HTLV-1 working group.

“But we need the support of the WHO and Australian Government to accelerate research and implement these strategies.”

ASHM have been advocating for the inclusion of HTLV-1 in the yet-to-be released Fifth National Aboriginal and Torres Strait Islander Blood-Borne Viruses and Sexually Transmissible Infections Strategy as a Priority Action.

Read the full letter available on the Global Virus Network website

HIV PrEP available on PBS in Australia from 1 April / Links to Clinical Resources

Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 21 March 2018

ASHM congratulates the Federal Health Minister, the Hon. Greg Hunt’s announcement of a landmark in HIV prevention to approve HIV-prevention drugs – tenofovir with emtricitabine, known as PrEP – on the Pharmaceutical Benefits Scheme from 1 April, thereby providing broader access for any doctor or general practitioner to be able prescribe PrEP to an Australian resident who holds a current Medicare card.

“The public health benefits are clear, undeniable and transformative benefiting individuals at medium- to high-risk of HIV infection and towards driving a substantial reduction in HIV transmissions in Australia,” said ASHM President, Associate Professor Bloch.

Access Links to Clinical Resources supporting the HIV workforce

  • The definitions of risk for HIV, guidelines and procedures for the appropriate administration and monitoring of PrEP can be found here: ASHM HIV pre-exposure prophylaxis: clinical guidelines
  • The Australian Federation of AIDS Organisations (AFAO) and ASHM have produced a PrEP Fact Sheet to assist PrEP users and people with an interest in using PrEP to understand what subsidised access to PrEP through the PBS means. Access the factsheet here
  • ASHM continues to support the workforce to ensure access to PrEP and best practice in guidelines, training and resources. Access information here
  • The Pharmaceutical Society of Australia has a range of training to support pharmacists in preparing for PrEP on the PBS: www.psa.org.au

 

Australasian HIV&AIDS + Sexual Health Conferences – registrations closing soon

Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, October 2017

Registrations for these conferences are closing soon:

The Australasian HIV&AIDS Conference

The Australasian HIV&AIDS Conference is the premier HIV Conference in Australia and the Asia and Pacific region. The annual conference is run by ASHM as a platform for the dissemination and presentation of new and innovative research findings across the Australasian HIV sector.

Delegates to the conference come from a range of professional backgrounds including basic science, clinical medicine, community programs, education, epidemiology, indigenous health, international and regional issues, nursing and allied health, policy, primary care, public health and prevention, and social research.

Date: 6-8 November 2017

Location: National Convention Centre Canberra

Australasian Sexual Health Conference

The Australasian Sexual Health Alliance seeks to use the Australasian Sexual Health Conference to achieve its purpose of acknowledging and building on the specific expertise of sector partners in the common aims of improving national and local responses to sexual health in Australasia, in supporting and collaborating with close neighbouring countries to achieve these objectives.

Taking forward the agenda for re-thinking sexual health established by the 2016 Australasian Sexual Health Conference in Adelaide, this year’s interdisciplinary conference addresses how sexual health can be re-formed: firstly towards more integrated and personalised provision attuned to people’s needs; and secondly, to make more streamlined and cost-effective use of available resources.

Date: 7-9 November 2017

Location: National Convention Centre Canberra

Download conference flyers